Fig. 3

Overall survival associated with monosomal and complex karyotypes and with specific cytogenetic abnormalities occurring in ≥10% of patients

Overall survival associated with monosomal and complex karyotypes and with specific cytogenetic abnormalities occurring in ≥10% of patients